SPOTLIGHT -
How Advanced Analytics Drive Digital Transformation
From Lab to Life: Bringing Medicines to Patients Faster by Accelerating End-to-End Drug Development
The future of life sciences and healthcare
Genpact’s latest report, Life Sciences and Healthcare in the Age of Instinct, explores three major trends shaping the future of healthcare.
Positioning Biobanking Assets for Maximum Value
As precision medicine grows, so, too, does demand for biobanking services, offering both strategic and financial investors a significant opportunity for value creation.
Exclusivity versus Collaboration: Which is Best for Successful Clinical Trials?
Pharmaceutical Executive® APEX Awards
The Pharmaceutical Executive® APEX Awards feature some of today’s best creative work in the pharmaceutical industry. Come and see how you did, along with other agencies, at our live virtual event on September 9.
From Lab to Life: Key Drivers of Customer Engagement That Redefine Commercialization and Product Development
Predicting Physician Prescribing Behavior Using Artificial Intelligence
Twenty Years of Growth at Frontage Labs
The Current State of Drug Pricing and Forecasts for the Future
Inorganic Growth Strategies in Precision Medicine
Navigating the Digital Transformation Journey
For pharma companies engaged in digital transformation, LabVantage Pharma is a purpose-built, pre-validated LIMS to bring your labs along the transformation journey.
Using Digital Combination Therapies to Improve Patient Outcomes
Improve the Drug Discovery Tool Box
This whitepaper looks at the requirements for High Throughput Screening, High Content Screening and Surface Plasmon Resonance and makes suggestions for how to make these processes more flexible and repeatable.
The Role of Hubs in Improving Patient Adherence
Strategic Partnerships for Unlocking Product Potential
A New Paradigm in Research and Clinical Data Collection
ERP Implementation Case Studies
The Future of Medicine is Smart
This white paper describes how digitizing medicines can drive patient engagement, reduce non-adherence, and enhance supply chain visibility.
The Impact of False Starts on Omnichannel Efforts
What Life Sciences Companies Need to Know From Startup to Commercialization
Analysis of Risk-Based Quality Management Approach - White Paper
This white paper investigates best practices and tangible benefits associated with a risk-based quality management (RBQM) approach to clinical trial management.
Flip the Script
Life sciences transformations rarely fail because of what was in the plan. They fail because of what was not. Explore five trends that will determine their success in coming years.
Patient Support Launch Guide: Novel Therapies
Gain actionable insights from Lash Group experts, leveraging 30+ years of experience launching new programs to help you ensure patient support success.
Analysis of Risk-Based Quality Management Approach
Acoustic Ejection Mass Spectrometry: The Era of High-Throughput Mass Spectrometry
Digital patient solutions: the secret to delivering and securing adoption
Industry experts cover how to develop digital patient solutions that address real unmet needs and secure adoption.
Gaining Payer Attention Through Digital Innovation
In this case study, learn how to increase payer engagement, drive awareness, monitor competition, and leverage insights to enhance strategic plans and launch success.
Solving access, reimbursement, and PAP awareness problems
With bigger patient access and affordability barriers given the new normal of COVID-19, see why field services are more important than ever. Read now.
Patient Support Programs: Considerations for Crisis Management and Risk Mitigation
This whitepaper discusses the importance of patient support programs and why a robust risk mitigation plan is critical to ensure that patients receive their therapy during crises.